Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Garlic Tablets for Prevention of Nosocomial Infections in ICU
NCT06833125Phase 3Enrolling by invitation
- Sponsor
- Alexandria University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Tomex Plus in nosocomial infection (2 arms), sponsored by Alexandria University. Primary endpoint: Occurrence of central line-associated bloodstream infections, catheter- associated urinary tract infections, surgical site infections and ventilator- associated pneumonia at 1 year. Started Mar 2025; status: enrolling by invitation.
02
Drugs
Tomex Plus
03
Conditions
nosocomial infection
Beyond the preview
Go deeper on NCT06833125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06833125.